Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Trial of Metronomic Treatment in Children and Adolescents With Recurrent or Progressive Neuroblastoma (NB)

NCT02641314 is registered in ClinicalTrials.gov with University of Cologne as lead sponsor.

NCT NCT02641314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02641314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Trial of Metronomic Treatment in Children and Adolescents With Recurrent or Progressive Neuroblastoma (NB)
Lead sponsor
University of Cologne
Phase
Phase 2
Overall status
Completed
Start date
December 22, 2016
Completion date
June 29, 2023
Enrollment
18 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent neuroblastoma